2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1023198793 D.D.S.MSC
Verify on CMS →

ROBERT DOLMAN, D.D.S.MSC

Oral and Maxillofacial Pathology Dentistry in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
122
Medicare Part D claims · 51 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
Industry payments
$65.84
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERT DOLMAN, D.D.S.MSC is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 122 claims across 51 beneficiaries . Industry payments of $65.84 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROBERT DOLMAN, D.D.S.MSC filed 122 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROBERT DOLMAN, D.D.S.MSC at a glance

Quality data not reported

NPI registry status

Active

Issued 10/17/2006

NPI 1023198793

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

122 60% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in New York

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among New York providers

New York providers

Oral and Maxillofacial Pathology Dentistry share within New York

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT DOLMAN, D.D.S.MSC is a Oral and Maxillofacial Pathology Dentistry provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.D.S.MSC. NPI: 1023198793. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT DOLMAN, D.D.S.MSC appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding D.D.S.MSC credentials at 12 E 41ST ST, NEW YORK, NY, 10017, with a listed phone of (212) 696-0167. NPI 1023198793 was issued on 10/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOLMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 122 prescription claims written by this provider, covering 51 Medicare beneficiaries and totaling roughly $643 in drug spend, with an opioid prescribing rate of 13.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12 E 41ST ST
NEW YORK, NY 10017

Provider Details

NPI 1023198793
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials D.D.S.MSC
Gender Male
NPI Issued 10/17/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT DOLMAN, D.D.S.MSC. Source: openpaymentsdata.cms.gov.

Total received

$66

Largest payer

Southern Anesthesia & Surgical, Inc (dba Ace Southern)

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROBERT DOLMAN, D.D.S.MSC. To verify ROBERT DOLMAN, D.D.S.MSC's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

122
Total Claims
$643
Total Drug Cost
51
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
122
Total Day Supply
836
Brand Drug Cost
$0
Generic Drug Cost
$643
Opioid Claims
16 (13.1% rate)
Antibiotic Claims
49

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
0.83
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amoxicillin
35
Ibuprofen
30
Chlorhexidine Gluconate
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How ROBERT DOLMAN, D.D.S.MSC fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

ROBERT DOLMAN, D.D.S.MSC's 122 claims are below the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as DOLMAN.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT DOLMAN, D.D.S.MSC's specialty?
ROBERT DOLMAN, D.D.S.MSC specializes in Oral and Maxillofacial Pathology Dentistry and practices in NEW YORK, New York. Credentials: D.D.S.MSC.
How much does ROBERT DOLMAN, D.D.S.MSC prescribe under Medicare Part D?
In 2023, ROBERT DOLMAN, D.D.S.MSC wrote 122 Medicare Part D claims totaling $643 in drug costs for 51 beneficiaries.
Where is ROBERT DOLMAN, D.D.S.MSC located?
ROBERT DOLMAN, D.D.S.MSC is located at 12 E 41ST ST, NEW YORK, NY, 10017. Phone: (212) 696-0167.
What is ROBERT DOLMAN, D.D.S.MSC's NPI number?
ROBERT DOLMAN, D.D.S.MSC's National Provider Identifier (NPI) is 1023198793, issued on 10/17/2006.
Does ROBERT DOLMAN, D.D.S.MSC prescribe opioids?
Yes, ROBERT DOLMAN, D.D.S.MSC had 16 opioid claims in 2023 with an opioid prescribing rate of 13.1%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does ROBERT DOLMAN, D.D.S.MSC prescribe most often?
Based on 2023 Medicare Part D data, ROBERT DOLMAN, D.D.S.MSC's most frequently prescribed drugs include Amoxicillin, Ibuprofen, Chlorhexidine Gluconate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT DOLMAN, D.D.S.MSC accept Medicare?
ROBERT DOLMAN, D.D.S.MSC appears in CMS Medicare data with 122 Part D claims and 51 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT DOLMAN, D.D.S.MSC's credentials?
ROBERT DOLMAN, D.D.S.MSC's NPI is 1023198793 with credentials D.D.S.MSC. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology